Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) is now available.
SMS Pharmaceuticals Limited has released its investor presentation for the quarter ending June 30, 2025, in compliance with SEBI regulations. This presentation, now available on the company’s website, provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder relations.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company is known for its robust product portfolio and commitment to quality, serving a diverse market with a strong emphasis on innovation and customer satisfaction.
Average Trading Volume: 8,022
Technical Sentiment Signal: Buy
Current Market Cap: 19.85B INR
See more data about SMSPHARMA stock on TipRanks’ Stock Analysis page.